These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 31489705)

  • 61. Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction.
    Kang SW; Jeon S; Yoo HS; Chung SJ; Lee PH; Sohn YH; Yun M; Evans AC; Ye BS
    Neurology; 2019 Apr; 92(17):e2015-e2026. PubMed ID: 30944239
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Amyloid imaging with [(18)F]florbetapir in geriatric depression: early-onset versus late-onset.
    Tateno A; Sakayori T; Higuchi M; Suhara T; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 Jul; 30(7):720-8. PubMed ID: 25335941
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.
    Loewenstein DA; Curiel RE; Wright C; Sun X; Alperin N; Crocco E; Czaja SJ; Raffo A; Penate A; Melo J; Capp K; Gamez M; Duara R
    J Alzheimers Dis; 2017; 56(3):1119-1126. PubMed ID: 28106554
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
    Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
    J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
    Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
    J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease.
    Winer JR; Maass A; Pressman P; Stiver J; Schonhaut DR; Baker SL; Kramer J; Rabinovici GD; Jagust WJ
    JAMA Neurol; 2018 Feb; 75(2):227-235. PubMed ID: 29228071
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential associations between depression and cognitive function in MCI and AD: a cross-sectional study.
    Lee CH; Kim DH; Moon YS
    Int Psychogeriatr; 2019 Aug; 31(8):1151-1158. PubMed ID: 30696505
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly.
    Dhilla Albers A; Asafu-Adjei J; Delaney MK; Kelly KE; Gomez-Isla T; Blacker D; Johnson KA; Sperling RA; Hyman BT; Betensky RA; Hastings L; Albers MW
    Ann Neurol; 2016 Dec; 80(6):846-857. PubMed ID: 27696605
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cerebral Amyloid Angiopathy Is Associated With Executive Dysfunction and Mild Cognitive Impairment.
    Case NF; Charlton A; Zwiers A; Batool S; McCreary CR; Hogan DB; Ismail Z; Zerna C; Coutts SB; Frayne R; Goodyear B; Haffenden A; Smith EE
    Stroke; 2016 Aug; 47(8):2010-6. PubMed ID: 27338926
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment.
    Loewenstein DA; Curiel RE; DeKosky S; Bauer RM; Rosselli M; Guinjoan SM; Adjouadi M; Peñate A; Barker WW; Goenaga S; Golde T; Greig-Custo MT; Hanson KS; Li C; Lizarraga G; Marsiske M; Duara R
    Neurology; 2018 Sep; 91(10):e976-e984. PubMed ID: 30076274
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A biomarker study in long-lasting amnestic mild cognitive impairment.
    Cerami C; Dodich A; Iannaccone S; Magnani G; Santangelo R; Presotto L; Marcone A; Gianolli L; Cappa SF; Perani D
    Alzheimers Res Ther; 2018 Apr; 10(1):42. PubMed ID: 29695292
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Progressive amnestic cognitive impairment in a middle-aged patient with developmental language disorder: a case report.
    Takaya M; Ishii K; Kiguchi K; Saigoh K; Shirakawa O
    J Med Case Rep; 2020 Sep; 14(1):139. PubMed ID: 32878644
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association between Cerebral Amyloid Deposition and Clinical Factors Including Cognitive Function in Geriatric Depression: Pilot Study Using Amyloid Positron Emission Tomography.
    Kim HG; Kong EJ; Cheon EJ; Kim HW; Koo BH
    Clin Psychopharmacol Neurosci; 2016 Nov; 14(4):378-382. PubMed ID: 27776391
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pathways linking hypertension and depression with mild cognitive impairment in older adults.
    Kraynak TE; Andreescu C
    Int Psychogeriatr; 2022 Jun; 34(6):515-517. PubMed ID: 35287769
    [No Abstract]   [Full Text] [Related]  

  • 76. Brain Amyloid Deposition in Late-Life Depression.
    Pomara N; Imbimbo BP
    Biol Psychiatry; 2021 Apr; 89(8):e41-e42. PubMed ID: 33189332
    [No Abstract]   [Full Text] [Related]  

  • 77. Association between brain amyloid accumulation and neuropsychological characteristics in elders with depression and mild cognitive impairment.
    Youn H; Lee S; Han C; Kim SH; Jeong HG
    Int J Geriatr Psychiatry; 2019 Dec; 34(12):1907-1915. PubMed ID: 31489705
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.